These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34069262)

  • 21. Mass Spectrometry-Based Glycoproteomic Workflows for Cancer Biomarker Discovery.
    Doud EH; Yeh ES
    Technol Cancer Res Treat; 2023; 22():15330338221148811. PubMed ID: 36740994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in mass spectrometry driven O-glycoproteomics.
    Levery SB; Steentoft C; Halim A; Narimatsu Y; Clausen H; Vakhrushev SY
    Biochim Biophys Acta; 2015 Jan; 1850(1):33-42. PubMed ID: 25284204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma glycoproteomics delivers high-specificity disease biomarkers by detecting site-specific glycosylation abnormalities.
    Wessels HJCT; Kulkarni P; van Dael M; Suppers A; Willems E; Zijlstra F; Kragt E; Gloerich J; Schmit PO; Pengelley S; Marx K; van Gool AJ; Lefeber DJ
    J Adv Res; 2024 Jul; 61():179-192. PubMed ID: 37683725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
    Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
    BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of the interaction between lectin and serum prostate specific antigen in prostate cancer.
    Batabyal SK; Majhi R; Basu PS
    Neoplasma; 2009; 56(1):68-71. PubMed ID: 19152248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered glycosylation in prostate cancer.
    Drake RR; Jones EE; Powers TW; Nyalwidhe JO
    Adv Cancer Res; 2015; 126():345-82. PubMed ID: 25727153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innovative biomarkers for prostate cancer early diagnosis and progression.
    You J; Cozzi P; Walsh B; Willcox M; Kearsley J; Russell P; Li Y
    Crit Rev Oncol Hematol; 2010 Jan; 73(1):10-22. PubMed ID: 19328712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of urinary PSA glycosylation is not indicative of high-risk prostate cancer.
    Barrabés S; Llop E; Ferrer-Batallé M; Ramírez M; Aleixandre RN; Perry AS; de Llorens R; Peracaula R
    Clin Chim Acta; 2017 Jul; 470():97-102. PubMed ID: 28495148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deciphering the Properties and Functions of Glycoproteins Using Quantitative Proteomics.
    Xu S; Xu X; Wu R
    J Proteome Res; 2023 Jun; 22(6):1571-1588. PubMed ID: 37010087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery.
    Tanase CP; Codrici E; Popescu ID; Mihai S; Enciu AM; Necula LG; Preda A; Ismail G; Albulescu R
    Oncotarget; 2017 Mar; 8(11):18497-18512. PubMed ID: 28061466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics.
    Spiciarich DR; Nolley R; Maund SL; Purcell SC; Herschel J; Iavarone AT; Peehl DM; Bertozzi CR
    Angew Chem Int Ed Engl; 2017 Jul; 56(31):8992-8997. PubMed ID: 28649697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global and Targeted Proteomics of Prostate Cancer Cell Secretome: Combination of 2-Dimensional Image-Converted Analysis of Liquid Chromatography and Mass Spectrometry and In Silico Selection Selected Reaction Monitoring Analysis.
    Nurdin A; Hoshi Y; Yoneyama T; Miyauchi E; Tachikawa M; Watanabe M; Terasaki T
    J Pharm Sci; 2016 Nov; 105(11):3440-3452. PubMed ID: 27665127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker.
    Worst TS; von Hardenberg J; Gross JC; Erben P; Schnölzer M; Hausser I; Bugert P; Michel MS; Boutros M
    Mol Cell Proteomics; 2017 Jun; 16(6):998-1008. PubMed ID: 28396511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry.
    Khoo A; Liu LY; Nyalwidhe JO; Semmes OJ; Vesprini D; Downes MR; Boutros PC; Liu SK; Kislinger T
    Nat Rev Urol; 2021 Dec; 18(12):707-724. PubMed ID: 34453155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for Proteome-Wide Quantification of Glycosylation Macro- and Micro-Heterogeneity.
    Fang P; Ji Y; Oellerich T; Urlaub H; Pan KT
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular markers of prostate cancer.
    Bradford TJ; Tomlins SA; Wang X; Chinnaiyan AM
    Urol Oncol; 2006; 24(6):538-51. PubMed ID: 17138135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycosylation of urinary prostate-specific antigen in benign hyperplasia and cancer: assessment by lectin-binding patterns.
    Janković MM; Kosanović MM
    Clin Biochem; 2005 Jan; 38(1):58-65. PubMed ID: 15607318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In the search of novel urine biomarkers for the early diagnosis of prostate cancer. Intracellular or secreted proteins as the target group? Where and how to search for possible biomarkers useful in the everyday clinical practice.
    Katafigioti A; Katafigiotis I; Sfoungaristos S; Alamanis C; Stravodimos K; Anastasiou I; Roumelioti E; Duvdevani M; Constantinides C
    Arch Ital Urol Androl; 2016 Oct; 88(3):195-200. PubMed ID: 27711093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. O-glycosylated clusterin as a sensitive marker for diagnosing early stages of prostate cancer.
    Kazuno S; Fujimura T; Fujime M; Miura Y; Ueno T
    Prostate; 2021 Feb; 81(3):170-181. PubMed ID: 33347638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
    Findeisen P; Neumaier M
    Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.